A media fill (also known as process simulation) test is a critical microbiological test carried out to assess the performance of an aseptic manufacturing procedure by replacing the pharmaceutical or beverage product with a sterile culture media. Aseptic manufacturing is a complex process used in the pharmaceutical, food, and beverage industries. Good manufacturing practices (GMP) require pharmaceutical and beverage companies to regularly perform media fill tests to verify the microbiological state of their aseptic production process.
The nutrient medium is selected based on the product quantity and the selectivity, clarity, concentration, and suitability of the medium for sterilization. The process simulation test should imitate, as closely as possible, the routine aseptic manufacturing process and include all critical subsequent manufacturing steps.
A well-designed media fill test guarantees representation of all aseptic manipulations performed during production. These include preparation and assembly of product containers, transfer of the product containers to the fill area, and all steps downstream from the sterilizing filter up to product release, including packaging into finished product containers.
After filling, finished product containers with medium should then be incubated for microbial growth. Containers with contamination are expected to exhibit observable evidence of microbial growth after suitable incubation. Media fill tests are also accompanied by surface and air monitoring in the critical production area.
Culture media used in media fill tests should support the growth of a wide variety of microorganisms, including aerobic bacteria, yeast, and mold (non-selective medium). Soybean casein digest medium (SCDM), also known as tryptone soya broth (TSB), is the most common medium used in pharma media fill tests due to its low selectivity, growth-promoting properties, high solubility, and media clarity.
During media selection, growth promotion tests are used to ensure the media supports microorganism growth. This is an essential control for media fills because the desired test result of “no growth” is valid only by demonstrating the medium’s ability to support microbial growth. The organisms to be tested are stated by pharmacopeia.
For sterility tests in aseptic beverage filling lines, the most widely used medium is Linden Grain medium (LGM). LGM provides a sensitive, nutritive broth for microorganisms (e.g. yeast, mold, bacteria). The pH is adjusted to match the pH of the beverage filled through the line. After incubation, turbidity caused by microbial contamination can be easily checked due to the clear, light-yellow color of LGM.
The incubation temperature should be suitable for the recovery of bioburden and environmental isolates. For regulatory compliance, media-filled containers are incubated at two temperatures – the initial incubation at 20–25 °C for 7 days, and then at 30–35 °C for 7 days. This two-stage process provides an opportunity for fungal growth, before the plates are overwhelmed by bacterial growth.
Normally process simulation tests should be repeated twice a year in pharmaceutical production, once a year in the beverages industry, per shift and process. Three media fill tests should be conducted on three separate days to initially qualify an aseptic process before starting the production. Additionally, media fill tests should be conducted whenever significant changes are made to the aseptic process (e.g., changes in personnel, components, or equipment) and whenever there is evidence of a failure to maintain product sterility.
An assumption made during media fill tests is that all other factors that could affect product sterility, such as the sterility of containers and closures, and the efficiency of the equipment and filtration stages, are satisfactory and validated separately. The results of media fill trials demonstrate how likely it is for unit contamination to occur throughout the normal filling process.
In this 10-minute quick learning tutorial our expert Adèle Gisselmann will guide you through the requirements for aseptic manufacturers when selecting media for media fill tests or aseptic process simulations.
Our granulated media has excellent cold filtration properties to avoid clogged filters. Our media is triple-wrapped and cleanroom ready.
We offer a broad portfolio for microbial monitoring of aseptic pharmaceutical manufacturing including convenient and ready to use 55 mm and 90 mm agar plates, swabs as well as viable air samplers for ambient air and compressed gas testing.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.